You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 106 No. 1, JULY 1960 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Double Blind Control Study of Antihypertensive Agents

I. Comparative Effectiveness of Reserpine, Reserpine and Hydralazine, and Three Ganglionic Blocking Agents, Chlorisondamine, Mecamyamine, and Pentolinium Tartrate

VETERANS ADMINISTRATION COOPERATIVE STUDY ON ANTIHYPERTENSIVE AGENTS

Arch Intern Med. 1960;106(1):81-96.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the past decade a number of drugs have been developed for the specific purpose of reducing blood pressure in hypertensive patients. Attempts to evaluate these agents definitively have been hindered either by lack of suitable controls, failure to eliminate bias, or by insufficient numbers of patients. Inevitably, under such circumstances, differences of opinion have arisen as to the relative effectiveness, tolerability, and safety of the various antihypertensive agents now in general clinical use. Furthermore, well-controlled data have been lacking on the value of blood pressure reduction in preventing or delaying cardiovascular-renal damage in hypertensive disease of mild and moderate severity.

In view of the obvious importance of the problem it was decided to institute a program which would permit more reliable comparisons of the therapeutic effectiveness of antihypertensive agents. A cooperative investigation was best suited for the purpose, since it encompasses a sufficiently large series of patients to permit . . . [Full Text PDF of this Article]


Author Affiliations

Washington, D.C.


Footnotes

Submitted for publication Sept. 28, 1959.

Initial report. Participants: Mark L. Armstrong, M.D.; John L. Bakke, M.D.; Loyal L. Conrad, M.D.; Edward D. Freis, M.D. (Chairman); Rudolph E. Fremont, M.D.; Walter M. Kirkendall, M.D.; Clifford G. Pilz, M.D.; Eli A. Ramirez, M.D.; David W. Richardson, M.D., and John H. Williams Jr., B.A.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.